Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $2.6900 (-3.06%) ($2.6900 - $2.6900) on Tue. Apr. 12, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.85% (three month average) | RSI | 32 | Latest Price | $2.6900(-3.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -3.3% a day on average for past five trading days. | Weekly Trend | CGEN declines -5.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) PAVE(99%) QQQ(99%) XLK(96%) SKYY(90%) SPY(90%) | Factors Impacting CGEN price | CGEN will decline at least -1.925% in a week (0% probabilities). TLT(-78%) UNG(-33%) TIP(-17%) UUP(-9%) TBT(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.925% (StdDev 3.85%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-8.41(-412.64%) | Resistance Level | $3.16 | 5 Day Moving Average | $2.94(-8.5%) | 10 Day Moving Average | $3.09(-12.94%) | 20 Day Moving Average | $3.16(-14.87%) | To recent high | -32.6% | To recent low | 0% | Market Cap | $222m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |